Brief report: Free prostate-specific antigen test utilization. Consistency with guidelines.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1490212)

Published in J Gen Intern Med on September 01, 2005

Authors

Brian R Jackson1, William L Roberts

Author Affiliations

1: Department of Pathology, University of Utah, Salt Lake City, Utah, USA. brian.jackson@aruplab.com

Articles cited by this

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA (1998) 5.87

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol (1994) 5.31

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA (2003) 3.57

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med (1997) 3.24

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med (2004) 1.55

Prostate-specific antigen screening in elderly men. J Natl Cancer Inst (2003) 1.16

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. J Urol (1997) 1.12

Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med (2000) 1.02

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology (2001) 0.98

Prostate-specific antigen testing practices and outcomes. J Gen Intern Med (1998) 0.91

Appropriateness of prostate-specific antigen testing. Am J Clin Pathol (2000) 0.82

Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer. Mayo Clin Proc (1997) 0.82

Articles by these authors

(truncated to the top 100)

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol (2011) 2.65

Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr (2005) 2.55

High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol (2008) 2.47

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol (2005) 2.22

Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem (2013) 1.96

Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem (2008) 1.94

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med (2011) 1.93

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation (2004) 1.93

Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem (2004) 1.80

Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. Clin Chem (2004) 1.64

A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol (2009) 1.56

Performance characteristics of five automated CA 19-9 assays. Am J Clin Pathol (2007) 1.52

Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am J Clin Pathol (2008) 1.48

Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem (2010) 1.44

Pediatric reference intervals for serum alpha-fetoprotein. Clin Chim Acta (2011) 1.41

Effects of hemoglobin C, D, E, and S traits on measurements of HbA1c by six methods. Clin Chim Acta (2012) 1.33

Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem (2011) 1.32

Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobin in the presence of hemoglobin S and C traits. Clin Chem (2004) 1.29

Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem (2010) 1.24

Performance characteristics of seven automated CA 15-3 assays. Am J Clin Pathol (2006) 1.23

Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. Clin Chem (2004) 1.17

Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta (2006) 1.15

Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. J Ren Nutr (2004) 1.07

Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults. Prev Cardiol (2006) 1.05

Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis (2012) 1.05

Performance characteristics of the IMMUNLITE 2000 erythropoietin assay. Clin Chim Acta (2004) 1.04

Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem (2006) 1.04

Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.03

Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem (2004) 1.02

Second-trimester reference intervals for thyroid tests: the role of ethnicity. Clin Chem (2007) 1.02

Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. Am J Clin Pathol (2008) 1.02

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration. J Urol (2012) 1.00

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper. Circulation (2004) 0.99

The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays. Am J Clin Pathol (2006) 0.99

Performance characteristics of seven automated CA 125 assays. Am J Clin Pathol (2006) 0.99

Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection. Clin Chim Acta (2004) 0.97

Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol (2004) 0.96

Performance characteristics of six IMMULITE 2000 TORCH assays. Am J Clin Pathol (2006) 0.96

Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem (2005) 0.95

Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Clin Biochem (2004) 0.94

Comparison of five automated serum and whole blood folate assays. Am J Clin Pathol (2003) 0.94

Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol (2005) 0.93

Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment. Am J Cardiol (2005) 0.92

Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay. Clin Chim Acta (2012) 0.92

Rapid analysis of 25-hydroxyvitamin D(2) and D(3) by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am J Clin Pathol (2010) 0.91

Residents from five training programs report improvements in knowledge, attitudes and skills after a rotation with a hospice program. J Cancer Educ (2003) 0.90

Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol (2006) 0.88

The healthcare burden imposed by liver disease in aging Baby Boomers. Curr Gastroenterol Rep (2010) 0.88

Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine. Clin Biochem (2008) 0.87

Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the Partnership for the Accurate Testing of Hormones. Clin Chem (2012) 0.86

Ethnic differences in first-trimester thyroid reference intervals. Clin Chem (2011) 0.85

False-positive AxSYM cardiac troponin I results in a 53-year-old woman. Arch Pathol Lab Med (2002) 0.85

Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study. Ann Clin Lab Sci (2011) 0.85

Performance characteristics of five automated serum cortisol immunoassays. Clin Biochem (2004) 0.85

Pediatric reference intervals for random urine calcium, phosphorus and total protein. Pediatr Nephrol (2010) 0.85

Five-year summary of COMLEX-USA level 2-PE examinee performance and survey data. J Am Osteopath Assoc (2010) 0.83

Age and gender specific pediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid. Clin Chim Acta (2011) 0.83

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk? Am Heart J (2007) 0.82

Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum. Clin Biochem (2010) 0.82

Performance characteristics of seven automated thyroxine and T-uptake methods. Clin Chim Acta (2006) 0.82

Solid phase extraction procedure for urinary organic acid analysis by gas chromatography mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.82

The rights and freedoms gradient of health: evidence from a cross-national study. Front Psychol (2012) 0.82

Pediatric reference intervals for seven common coagulation assays. Clin Chem (2005) 0.81

Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. Am J Clin Pathol (2004) 0.81

Limitations of the Hoffman approach to determine pediatric reference intervals for two steroids. Clin Biochem (2010) 0.81

Pediatric reference intervals for serum copper and zinc. Clin Chim Acta (2011) 0.81

Adrenal steroid concentrations in children seven to seventeen years of age. J Pediatr Endocrinol Metab (2007) 0.81

Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. Am J Nephrol (2013) 0.80

Performance characteristics of an automated high-sensitivity C-reactive protein assay on the Dimension RXL analyzer. Clin Chim Acta (2002) 0.80

Performance characteristics of five cardiac Troponin I assays. Clin Chim Acta (2010) 0.80

Analysis of catecholamines in urine by positive-ion electrospray tandem mass spectrometry. Clin Chem (2002) 0.80

Relationships between high-stakes clinical skills exam scores and program director global competency ratings of first-year pediatric residents. Med Educ Online (2011) 0.80

Teaching pediatric laboratory medicine to pathology residents. Arch Pathol Lab Med (2006) 0.80

Detection of macro-creatine kinase and macroamylase by polyethylene glycol precipitation and ultrafiltration methods. Clin Chim Acta (2011) 0.79

Automated transport and sorting system in a large reference laboratory: part 2. Implementation of the system and performance measures over three years. Clin Chem (2002) 0.79

The effect of increased fetal hemoglobin on 7 common Hb A1c assay methods. Clin Chem (2012) 0.79

Performance characteristics of the ARCHITECT Galectin-3 assay. Clin Biochem (2012) 0.79

Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem (2005) 0.79

Performance characteristics of six intact parathyroid hormone assays. Am J Clin Pathol (2010) 0.78

Performance characteristics of a new Immulite(®) 2000 system erythropoietin assay. Clin Chim Acta (2010) 0.78

Microalbuminuria in acute burn injury. J Burn Care Res (2008) 0.78

Performance characteristics of an immunoturbidimetric assay for lipoprotein-associated phospholipase A2. Clin Chim Acta (2009) 0.78

Pediatric reference intervals for uncommon bleeding and thrombotic disorders. J Pediatr (2006) 0.78

Performance characteristics of six homocysteine assays. Am J Clin Pathol (2008) 0.78

Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study. Clin Chim Acta (2008) 0.78

Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays. Clin Chem (2002) 0.78

Performance characteristics of four immunonephelometric assays for the quantitative determination of IgA and IgM in cerebrospinal fluid. Am J Clin Pathol (2003) 0.77

Patient result median monitoring for clinical laboratory quality control. Clin Chim Acta (2011) 0.77

Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. Clin Chem (2002) 0.77

Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer. Am J Clin Pathol (2002) 0.77

Pediatric reference intervals for four serum bone markers using two automated immunoassays. Clin Chim Acta (2012) 0.77

Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1. J Pediatr Endocrinol Metab (2011) 0.77

Effects of beta thalassemia minor on results of six glycated hemoglobin methods. Clin Chim Acta (2004) 0.77

Performance characteristics of a recombinant enzymatic cycling assay for quantification of total homocysteine in serum or plasma. Clin Chim Acta (2004) 0.76

Functional sensitivity of seven automated thyroid stimulating hormone immunoassays. Clin Chim Acta (2011) 0.76

Clinical skills assessment of procedural and advanced communication skills: performance expectations of residency program directors. Med Educ Online (2012) 0.75

Phenytoin overview--metabolite interference in some immunoassays could be clinically important. Arch Pathol Lab Med (2004) 0.75

25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease. Clin Nephrol (2012) 0.75

Investigation of standardized patient ratings of humanistic competence on a medical licensure examination using Many-Facet Rasch Measurement and generalizability theory. Adv Health Sci Educ Theory Pract (2012) 0.75